RMS Scientific Services: Elevating Pharmaceutical Solutions Through Precision, Compliance & Collaboration

Pinak Patel, Founder

Pinak Patel

Founder

The Indian pharmaceutical sector has witnessed unprecedented growth in recent years, propelled by domestic demand and burgeoning export op­portunities. However, this growth has been accompanied by heightened regulatory scrutiny from domestic agen­cies and international counterparts. The aftermath of the COVID-19 pandemic has further accentuated the focus on quality assurance, driving pharmaceutical companies to seek reliable partners capable of meeting global standards. Against this backdrop, RMS Scientific Services has carved a niche for itself by offering comprehensive analytical solu­tions tailored to the exacting requirements of the indus­try. With a keen understanding of the evolving regulatory landscape, RMS Scientific Services is adept at navigating complex compliance frameworks to ensure the highest standards of quality and integrity.

Founded on the principles of precision and innovation, RMS Scientific Services has emerged as a trusted partner for pharmaceutical companies seeking superior analytical methods development and validation solutions. Initially, the firm ventured into the field with a specialization in impurity profiling, which is distinct from method development. Upon the commencement of method development by clients or industries, it often identifies certain unwanted compounds or specific impurities previously undiscovered in its projects. "Clients provide us with analytical data, including mass spectrometry and various forms of nuclear magnetic resonance [NMR], such as 1H NMR, 13C NMR, and GC/GC-MS, and elemental analysis. Utilizing this data, we potentially analyze and deduce impurities or unwanted products", says Pinak Patel, Founder.

As the clients witnessed the reliability of the company’s analyses, they entrusted the company with full project responsibilities, enabling it to initiate method development encompassing various techniques such as HPLC, Dissolution profiling, Ion Chromatography, GC-MS, ICP, and ICP-MS. Subsequently, the scope expanded to encompass a comprehensive range of analytical testing. While RMS Scientific Services offers a breadth of analytical services, its core expertise remains in impurity profiling, the foundation upon which the analytical method development packages are built. Presently, the offerings include chromatography, notably HPLC, GC, and ion chromatography. In addition, the company extends its services to encompass third-party analysis, including NMR, SEM-EDAX analysis, Thermal analysis like TGA, DSC, DTA, elemental analysis, and an expanding array of third-party testing services.

RMS Scientific Services and allied laboratories are committed to compliance with regulatory guidelines, be it those stipulated by the FDA or other international regulatory bodies. The company adopts a nuanced approach, tailoring its processes and protocols to align with the specific requirements of each client and project. Whether implementing Good Laboratory Practices (GLP) standards, adhering to FDA guidelines, or aligning with emerging regulatory frameworks in India, the firm ensures that every analysis meets the highest accuracy, precision, and robustness standards.

When it comes to precision, RMS Scientific Services ensures that method conditions are meticulously aligned

Pinak Patel, Founder

From the outset, the company fosters open dialogue and collaboration, seeking to understand the precise goals, constraints, and aspirations of its clients. Project timelines, deliverables, and milestones are meticulously outlined, with transparent communication as the cornerstone of every engagement. Whether it’s method development, validation studies, or customized synthesis of impurities, RMS Scientific Services operates as a trusted ally dedicated to delivering actionable insights and tangible results.

Precision, Accuracy, & Robustness

Precision, accuracy, and robustness are non-negotiable virtues in the realm of analytical sciences. RMS Scientific Services leaves no stone unturned in upholding these principles, employing rigorous validation protocols, instrument calibration, and method optimization to ensure the reliability and reproducibility of its results. From assay validations with a margin of error as low as 0.2 percent for product release to accommodating a slightly broader tolerance of two percent for R&D projects, the company calibrates its processes to the unique requirements of each endeavor.

When it comes to precision, RMS Scientific Services ensures that method conditions are meticulously aligned. However, the degree of precision is tailored to each client’s specific needs. Some clients may opt for streamlined methods and validation parameters, foregoing extensive precision requirements. Nevertheless, to uphold reliability, the firm maintains instrument calibration and alignment to uphold precision, accuracy, and robustness standards. Precision, being of paramount importance, is meticulously ensured through replicate analyses. Whether it’s a single day’s work or an ongoing project, routine replication validates precision adherence.

Robustness, which pertains to a method’s resilience to minor environmental variations, is another focal point. RMS Scientific Services takes measures to mitigate the impact of such variations on results, particularly for well-established processes. Even amidst the diverse array of daily projects, this commitment remains unwavering. For projects spanning longer durations, clients may request strict adherence to particular parameters. In such cases, it diligently executes these specifications. Accuracy, contingent on the project type, such as formulation or placebo studies, is rigorously upheld by regulatory guidelines.

Despite its relatively young presence in the market, RMS Scientific Services has swiftly garnered recognition for its innovative approach to analytical challenges. Beyond traditional analytical services, the company has embarked on ventures such as customized synthesis of impurities, leveraging its expertise to deliver bespoke solutions that address the unique needs of its clients. Embracing the ethos of ‘slow, standard, and operational,’ the company continues to push the boundaries of analytical excellence, guided by a relentless pursuit of scientific innovation and customer satisfaction. Bolstered by a track record of success and a steadfast commitment to excellence, the company can play an instrumental role in shaping the future of India’s pharmaceutical landscape. With a focus on continual improvement, innovation, and unwavering dedication to quality, RMS Scientific Services can lead the charge toward a brighter, more resilient future for the pharmaceutical industry.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.